Dare Bioscience Stock Market Value
| DARE Stock | USD 2.68 0.16 6.35% |
| Symbol | Dare |
Dare Bioscience Price To Book Ratio
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dare Bioscience. If investors know Dare will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dare Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.17) | Revenue Per Share | Quarterly Revenue Growth 1.734 | Return On Assets | Return On Equity |
The market value of Dare Bioscience is measured differently than its book value, which is the value of Dare that is recorded on the company's balance sheet. Investors also form their own opinion of Dare Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Dare Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dare Bioscience's market value can be influenced by many factors that don't directly affect Dare Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dare Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Dare Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dare Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Dare Bioscience 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Dare Bioscience's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Dare Bioscience.
| 04/24/2025 |
| 07/23/2025 |
If you would invest 0.00 in Dare Bioscience on April 24, 2025 and sell it all today you would earn a total of 0.00 from holding Dare Bioscience or generate 0.0% return on investment in Dare Bioscience over 90 days. Dare Bioscience is related to or competes with Connect Biopharma, VTv Therapeutics, Q32 Bio, CervoMed, Achieve Life, Cocrystal Pharma, and ENDRA Life. Dar Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing ... More
Dare Bioscience Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Dare Bioscience's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Dare Bioscience upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 30.71 | |||
| Value At Risk | (7.75) | |||
| Potential Upside | 5.16 |
Dare Bioscience Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Dare Bioscience's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Dare Bioscience's standard deviation. In reality, there are many statistical measures that can use Dare Bioscience historical prices to predict the future Dare Bioscience's volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | 0.0029 | |||
| Total Risk Alpha | (0.85) | |||
| Treynor Ratio | 0.162 |
Dare Bioscience Backtested Returns
Dare Bioscience secures Sharpe Ratio (or Efficiency) of -0.0228, which denotes the company had a -0.0228 % return per unit of risk over the last 3 months. Dare Bioscience exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Dare Bioscience's Mean Deviation of 2.36, standard deviation of 4.14, and Variance of 17.18 to check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.46, which means possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Dare Bioscience are expected to decrease at a much lower rate. During the bear market, Dare Bioscience is likely to outperform the market. At this point, Dare Bioscience has a negative expected return of -0.0981%. Please make sure to confirm Dare Bioscience's value at risk, rate of daily change, relative strength index, as well as the relationship between the kurtosis and market facilitation index , to decide if Dare Bioscience performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.14 |
Insignificant predictability
Dare Bioscience has insignificant predictability. Overlapping area represents the amount of predictability between Dare Bioscience time series from 24th of April 2025 to 8th of June 2025 and 8th of June 2025 to 23rd of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Dare Bioscience price movement. The serial correlation of 0.14 indicates that less than 14.0% of current Dare Bioscience price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.14 | |
| Spearman Rank Test | -0.16 | |
| Residual Average | 0.0 | |
| Price Variance | 0.08 |
Dare Bioscience lagged returns against current returns
Autocorrelation, which is Dare Bioscience stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Dare Bioscience's stock expected returns. We can calculate the autocorrelation of Dare Bioscience returns to help us make a trade decision. For example, suppose you find that Dare Bioscience has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Dare Bioscience regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Dare Bioscience stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Dare Bioscience stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Dare Bioscience stock over time.
Current vs Lagged Prices |
| Timeline |
Dare Bioscience Lagged Returns
When evaluating Dare Bioscience's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Dare Bioscience stock have on its future price. Dare Bioscience autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Dare Bioscience autocorrelation shows the relationship between Dare Bioscience stock current value and its past values and can show if there is a momentum factor associated with investing in Dare Bioscience.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Dare Bioscience is a strong investment it is important to analyze Dare Bioscience's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Dare Bioscience's future performance. For an informed investment choice regarding Dare Stock, refer to the following important reports:Check out Dare Bioscience Correlation, Dare Bioscience Volatility and Dare Bioscience Alpha and Beta module to complement your research on Dare Bioscience. For information on how to trade Dare Stock refer to our How to Trade Dare Stock guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Dare Bioscience technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.